The EIF5A2 gene helps cells make certain proteins needed for growth and movement. This gene plays an important role in keeping these processes balanced. When EIF5A2 does not work normally, cells may grow or move in less controlled ways, which is why it is studied closely in several cancers.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate activities in the body. Some genes hold the directions for producing proteins, the functional parts of cells. Others mainly help determine when certain processes happen, where they take place, and how strongly they run. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. You can read more about this topic in the LearnHub.
Overview
EIF5A2Gene function
What if the gene works
The EIF5A2 gene helps cells read genetic instructions and turn them into certain proteins. This supports normal cell growth and everyday cell activity.
Risk
What if the gene does not work
Milder to more severe variants in the EIF5A2 gene can change how well cells make the EIF5A2 protein. This may disrupt control of protein production and cell growth signals, with different variants affecting function to different degrees.
Treatment
What does that mean for your treatment
No EIF5A2-specific treatment or management approach is currently established for people with a pathogenic or loss-of-function variant in the EIF5A2 gene. In research, EIF5A2 activity is being studied as a cancer biomarker and possible drug target, but this has not yet led to drug choices used in clinical guidelines.
Gene function
What if the gene works
In your cells, the EIF5A2 gene helps turn genetic instructions into working proteins. Its protein supports the ribosome, the cell’s protein making machine, especially when a protein contains harder to build stretches. This steady job is part of what the EIF5A2 gene does in the body each day.
The EIF5A2 gene helps ribosomes read RNA instructions and join protein building blocks into a growing chain. This supports the normal production of many proteins your cells use every day.
Some protein instructions contain repeated patterns that are harder for ribosomes to move through. EIF5A2 helps the ribosome keep going so the full protein can be finished more smoothly.
By supporting protein production, EIF5A2 helps cells maintain routine growth, renewal, and daily work. A steady supply of proteins helps many tissues carry out normal cell activity.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not lead to any noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
When doctors describe how variants in the EIF5A2 gene affect protein function, they usually mean changes in protein shape, stability, or activation by hypusination (a chemical step that switches the protein on). Some variants may only partly reduce activity or weaken the protein’s interactions with the cell’s protein-making machinery. More disruptive variants can sharply lower stability or activity, while some DNA changes may instead increase how much EIF5A2 protein a cell makes.
How variants are linked to conditions
The EIF5A2 gene does not yet have a broadly confirmed link to a specific inherited health condition, although research on EIF5A2 gene variants and disease risk is still developing. If you have a confirmed EIF5A2-related finding on genetic testing, your doctor or genetic counselor can explain what it may mean in the context of your personal and family history.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely found in the general population. Most do not have a direct effect on health and instead represent normal human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce health risk related to EIF5A2 itself. In most settings, EIF5A2 is studied as one part of a bigger picture that also includes other genes, chance changes in cells, and everyday factors such as smoking, alcohol use, infections, and environmental exposures.
Inheritance of EIF5A2 variants
For how variants of the EIF5A2 gene are inherited, there is not yet a broadly confirmed inheritance pattern tied to a specific EIF5A2-related condition. This may become clearer as research develops, but at present EIF5A2 is not a gene with a well-established autosomal dominant, autosomal recessive, or X-linked condition used in routine clinical genetics. The EIF5A2 gene is located on chromosome 3, which is an autosome, so each person inherits one copy from each parent.
What does my EIF5A2 result mean for my family?
There isn't yet a broadly confirmed inheritance pattern tied to a specific inherited condition for EIF5A2, though this understanding can change as research develops. If you have a specific EIF5A2 result and questions about what it could mean for your family, a doctor or genetic counselor can help explain it in the context of your personal and family history.
Genetic information
Genetic testing
How you find out about variants
To find out about EIF5A2 variants, EIF5A2 genetic testing reads the DNA code in a blood, saliva, or tissue sample. Labs may look at just this gene or include it in a larger panel, exome, genome, or tumor test, then report whether a variant was found and what it may mean for care.
When should I consider getting a genetic test?
There isn't yet a broadly established, EIF5A2-specific clinical reason for testing. Testing decisions are best made with a doctor or genetic counselor based on your personal health and family history.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it reveals varies by the condition and the type of variant involved. Age, lifestyle, environment, and medical history, among other factors, also shape how the body functions over time. For conditions influenced by many genes, genetic information usually adds context rather than certainty and is best considered alongside other parts of care. In some cases, however, a genetic result can give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles a medicine, so the same treatment may work well for one person but not as well for another. Some variants change how quickly a drug is broken down or moved through the body, while others can influence how strongly the body responds to it. These differences are common and can affect benefit, side effects, or how sensitive someone is to a medication.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It studies gene and drug patterns to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body handles it. This information can support more personalized and informed treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the EIF5A2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in routine medication decisions, so general concerns about side effects, treatment response, or drug safety are best discussed with your doctor. EIF5A2 has been studied in cancer research because higher activity may affect how some tumors respond to chemotherapy, but this is not a standard guide for care.
History
In the early 2000s, researchers identified the EIF5A2 gene while studying a region of chromosome 3 that is often gained in several cancers. It was first brought to wider attention through work on ovarian cancer, where extra copies of this gene were linked to tumor growth. From these first observations, research expanded steadily, and EIF5A2 was later studied in liver, colorectal, lung, and other cancers. Over time, descriptions became more precise as scientists compared its activity in tumor tissue with normal tissue. Unlike genes that entered public discussion through a major news story or celebrity disclosure, EIF5A2 has remained mostly a research focused gene. Its history is mainly tied to laboratory studies that helped map cancer related genetic changes.